Predictive Disease Analytics Market Size, Share, Trends & Forecast, 2026-2034
REPORT DETAILS
Predictive Disease Analytics Market Size & Forecast, 2025-2034
The global predictive disease analytics market was valued at USD 3.49 billion in 2025. The market is expected to grow at a CAGR of 22.20% from 2026 to 2034. Key factors driving the demand include rising cases of chronic diseases, increasing government support, and technological advances.
Market Statistics
Predictive Disease Analytics Market Key Takeaways: Size, Components, Deployment & Regions
- North America accounted for a 40.8% share in 2025. This is due to the advancements in technology and the presence of leading market players.
- Asia Pacific is expected to witness rapid growth at an 18.3% CAGR. This is owing to the rise in the geriatric population and increasing chronic diseases in this region.
- The software segment led with a 56.7% share in 2025. The rise in digitalization and the rapid expansion of the IT industry contribute to the segment’s dominance.
- The on-premises segment held the largest share of 61.9% in 2025. The segment’s leading position is due to various benefits such as security, data privacy, performance, and latency.
- The healthcare providers segment is projected to grow at a 19.1% CAGR. The rapid expansion is driven by the growing adoption of electronic health records.
Note: Figures and projections outlined in this report are the result of Polaris Market Research’s proprietary analytical processes, grounded in the latest available datasets and market observations.
What Is Predictive Disease Analytics? Definition, Scope & Revenue Inclusions
The predictive disease analytics market includes advanced healthcare solutions that use AI, machine learning, and analytics to predict disease risk, treatment outcomes, and treatment responses. This is done by analyzing data from clinical sources, such as electronic medical records, medical imaging, and laboratory results.
How Predictive Disease Analytics Works: Data Integration, Model Training, Risk Scoring & Clinical Action
- Data Gathering – Data relating to patients is obtained using electronic health records (EHRs), laboratory test results, medical imaging, wearables, and other medical databases.
- Data Processing—The gathered data is then cleaned and organized for further analysis.
- Training of AI Models—Algorithms are used to analyze historical health data in order to detect disease patterns and risks.
- Disease Risk Assessment – The system provides estimates of the probability of developing and progressing into a disease for individual patients.
- Clinical Decisions Support – Physicians can take these predictions into account while making clinical decisions about treatment and disease prevention.
- Personalized Medicine—Individual patient’s treatment is planned, taking into account their predicted medical risks and history.
- Continuous Monitoring – As more patient data is gathered, the system continually recalculates predictions.
AI-Powered Revenue Cycle Management: The Candid Health Example
Growing technological advancements in the market are revolutionizing the overall healthcare industry. Several businesses are adopting artificial intelligence to improve their revenue streams. For instance, in July 2026, AI-powered billing and revenue cycle platform Candid Health raised $120 million in funding. With the funding, the company intends to scale its automation of reimbursement infrastructure for digital health and healthcare providers (source: businesswire.com).
Key Applications — Personalized Medicine, Operations, and Epidemiology
Technology is fundamental in global healthcare, as predictive analytics has become more useful in personal medicine, operational management, and epidemiology. The shift toward artificial intelligence has had a tremendously positive impact on the global market.
Predictive Analytics in EHR Systems, Adoption, and Decision-Making Across Healthcare
The increasingly pervasive use of predictive analytics in various healthcare applications results in better-individualized patient care, earlier interventions, and lower hospital expenses. Importantly, the technology already benefits a range of healthcare settings, including the biggest university institutions, healthcare insurance firms, and small private medical practices. Predictive analytics capabilities are currently prevalent in electronic health record (EHR) systems, and analysts anticipate that companies will continue to expand their offerings.
Healthcare professionals can use these predictive analytics techniques to identify the possibilities for making operational & clinical decisions that are more efficient in predicting trends and even controlling the spread of diseases. This is accomplished through the examination of both historical & current healthcare data.
Source: Polaris Market Research Analysis
To Understand More About this Research: Download Sample Report
Traditional Diagnosis vs Predictive Disease Analytics: Reactive vs Proactive Care
| Feature | Traditional Diagnosis | Predictive Disease Analytics |
| Method | Diagnosis of diseases based on symptoms | Identification of potential disease risks before symptoms become severe |
| Data Used | Clinical diagnosis and laboratory tests | Patient’s EHR, lab data, images, genomic information, wearable technology data |
| Decision Making | Dependent on the state of the patient at present time | Use of AI and data analytics for prediction of future diseases |
| Treatment Approach | Management of existing diseases | Early detection and prevention of disease development |
| Risk Prediction | Inability to predict future diseases | Identification of high-risk patients through predictive modeling |
| Patient Outcomes | Management of diagnosed diseases | Prevention of disease development and improvement of patient outcomes |
Source: Polaris Market Research Analysis
Key Market Drivers & Restraints.
Growth Drivers
Spurs in the adoption and launches of predictive analytics are set to escalate the predictive disease analytics market growth. The remarkable properties of solutions and appropriate patient care and outcomes have enhanced the demand for analytics in the healthcare industry. As a result, several businesses are contributing to the market. For instance, in January 2026, Tempus AI introduced Paige Predict to leverage artificial intelligence and the predictive capabilities of digital pathology for biomarker identification and oncogenic pathways across different cancer types (source: tempus.com).
Increasing cases of chronic diseases are another factor fueling the growth of the predictive analytics market. According to the CDC, chronic diseases are the foremost causes of death and disability in the U.S. Nearly 60% of adults have at least one chronic disease (source: cdc.gov). For example, as per the National Association of Chronic Disease Directors, chronic conditions like cancer, diabetes, and cardiovascular disease are the primary causes of death in the United States. The growing prevalence of chronic disease is improving the need for analytics to identify the risk of developing chronic conditions.
Growing Role in Precision Medicine
Predictive disease analytics is contributing to precision medicine through providing customized treatments that will suit each patient. The technology uses information from medical history, genetics, laboratory tests, and patients' lifestyles in predicting the possible risks of diseases as well as determining how the patients will react to the medication. In turn, this facilitates the selection of the best-suited treatments while avoiding unnecessary treatments. Moreover, precision medicine analytics is facilitating the discovery of biomarkers that facilitate targeted treatments. With continued adoption of data-driven technologies in healthcare institutions, personalized treatments have become increasingly available and accurate.
Adoption by Insurance and Payers
There is an increase in the use of predictive disease analytics by insurance companies and healthcare payers for better risk analysis and management of healthcare costs. Predictive analytics are useful in identifying high-risk patients, making predictions about the future health requirements of the patient, and implementing preventive care plans to keep the patient from being admitted to a hospital. Predictive analytics are used to prevent fraud, plan resources, and implement value-based care programs. Insurance companies get a better insight into the health status of the population through the analysis of health care data. Increasing emphasis on preventive health care is promoting more use of predictive analytics. It will help improve patient outcomes and also improve efficiency at the same time.
Hospital Efficiency Improvements
Healthcare institutions are now utilizing healthcare data analytics market solutions to increase efficiency and offer high-quality patient services. Prediction tools allow hospitals to discover patients at greater risk of developing complications or being readmitted to the hospital in order to take preventive measures in time. In addition, prediction tools allow healthcare facilities to manage their resources more effectively through prediction of patient arrivals, improvement of the availability of beds in hospitals, and scheduling of employees. The use of predictive data can be employed in emergency rooms for responding to changes in patient influxes in order to reduce waiting time. Through efficient use of resources and fast decision-making, predictive disease analytics help hospitals reduce costs and increase efficiency.
AI in Predictive Disease Analytics: Risk Stratification, Disease Progression & Clinical Decision Support
- Algorithms of AI analyze vast and complex datasets, from genomic data to lifestyle data, to identify patterns that are not easily identifiable.
- AI improves and refines clinical trial processes with the identification of the right data for studies and predicting their response to medication.
- It provides hyper-personalized health insights by pre-analyzing data on individual patients against population-level medical data trends. This enables practitioners to develop a tailored screening schedule and preventative strategy for patients.
- AI-enabled tools are expected to automate data analysis and provide actionable insights with support providers to identify high-risk patients, thereby enabling easy management of care while ensuring effective resource allocation.
Source: Polaris Market Research Analysis
Predictive Disease Analytics Market Segmentation by Component, Deployment, End User & Region
The market is primarily segmented based on component, deployment, end user, and region.
| By Component | By Deployment | By End User | By Region |
|
|
|
|
Source: Polaris Market Research Analysis
Predictive Disease Analytics Market by Component: Software, Services & Hardware
In 2025, the software segment dominated the market share. This is due to growing digitalization and the rapidly expanding IT industry. The software is widely adopted across many countries to provide essential tools for collecting, managing, analyzing, and integrating healthcare data. A large number of businesses are also investing in this segment. For instance, in February 2026, Optum introduced AI-powered prior authorization solutions. The solutions intend to deliver timely decisions that reduce delays and improve access to care. The Digital Auth Complete solution allows providers to submit requests in a quick and accurate manner. Payers can make efficient decisions and ensure clinical standards are met with InterQual Auth Accelerator (source: optum.com).
Most businesses across the globe use data analytics divisions to function their tools and services for future trends properly. Most analytic firms offer a full range of services to businesses. Extending the services provided by data analytics boosts the segment's growth even further.
Source: Polaris Market Research Analysis
Predictive Disease Analytics Market by Deployment: On-Premises vs. Cloud-Based
In 2025, the on-premises segment held the largest global share. This is attributed to various benefits such as security, data privacy, customization, performance, and latency. On-premises solutions offer greater flexibility and customization options, allowing organizations to tailor their predictive disease analytics software to their needs and workflows. Depending on the size and complexity of the data being analyzed, an on-premises solution is faster and more efficient than a cloud-based solution that relies on internet connectivity.
Predictive Disease Analytics Market by End User: Healthcare Payers, Providers & Others
Healthcare payers are the leading contributors to market development, as this segment primarily comprises insurance businesses, government agencies, & health-plan sponsors, and using these predictive tools is used to evaluate insurance claims, detect fraud claims, & evaluate disease risk assessment. As a result, most healthcare payers rely on analytics, which is why this segment is gaining huge momentum. As per a recent study, nearly 83% of healthcare practitioners believe that such predictive tools are one of their top strategic priorities.
Key Applications of Predictive Disease Analytics
| Application | Purpose |
| Prediction of Chronic Diseases | Provides predictions for patients with risks of developing certain diseases, including diabetes and heart diseases. |
| Cancer Risk Assessment | Offers analysis of the data from the patient in order to make estimates regarding cancer risk. |
| Predictions of Hospital Readmissions | Helps to predict which patients will require hospital readmission. |
| Forecasting of Infectious Diseases | Predicts the spread of infectious diseases to support outbreak response. |
| Personalized Treatment Planning | Uses data about the patient in order to make recommendations for treatment. |
| Population Health Management | Enables healthcare organizations to monitor disease prevalence and plan prevention strategies. |
Source: Polaris Market Research Analysis
Regulatory Landscape
The predictive disease analytics industry is governed by regulations that emphasize the protection of patient data, accuracy in clinical practice, and safe use of AI and machine learning in healthcare. Both the healthcare industry and technology suppliers are required to adhere to relevant laws and standards in order to develop and implement predictive analytics technology. In many cases, AI-driven tools used in the healthcare sector need to pass clinical testing demonstrating their safety and efficacy. There are also guidelines being developed by government institutions for promoting transparency and ethical use of AI in healthcare analytics. With the continuous growth of digital healthcare services, regulations are expected to evolve alongside.
Predictive Disease Analytics Market Regional Analysis: North America, Europe, Asia Pacific, Latin America & MEA
North America Led with 40.8% Share in 2025
North America accounted for the largest share of the global market in 2025. This is linked to advancements in technology and the prominence of industry participants, remarkably in the United States. The substantial funding provided to new players by venture capitalists is likely to fuel market growth. Augmented healthcare expenditure in the region is one of the key aspects of improving global revenue. According to the American Medical Association, health spending in the U.S. increased by 7.2% in 2024. It stood at USD 5.3 trillion, or USD 15,474 per capita. This growth rate closely matched the 7.4% rise in 2023.
Intensifying innovations in predictive analytics development techniques are anticipated to be key opportunities for well-known players. The proliferation of advanced technologies such as machine learning, artificial intelligence, and big data will likely boost market growth during the forecast period.
Asia Pacific to Witness Rapid Growth at 18.3% CAGR
Asia Pacific is expected to grow fastest during the forecast period due to the geriatric population and increasing chronic diseases in this region. With longer life expectancies and lower fertility rates, Asia Pacific is at the forefront of one of the most important global demographic trends. According to UNFPA, the number of older adults in the Asia Pacific is growing at an unprecedented rate. By 2050, 1 in 4 people in Asia and the Pacific will be over 60 years old. The population of older persons (aged over 60) in the region is projected to reach close to 1.3 billion people (source: unfpa.org). Older adults are often at risk for social isolation, which can lead to a range of negative health outcomes.
Analytics solutions help identify individuals at risk for social isolation and connect them with resources and services that can help them stay engaged with their communities. Subsequently, a growing older population is increasing the risks of various diseases, hence the demand for predictive analytics solutions. This is further responsible for augmenting the growth of the global market.
Source: Polaris Market Research Analysis
Predictive Disease Analytics Market Competitive Landscape & Leading Companies
The predictive disease analytics landscape is fiercely competitive, as stakeholder intelligence and strategy matter when it comes to market evolution and performance. Viable vendor strategies currently revolve around strategic placements of AI spending and partnerships based on a competitive positioning. A large revenue opportunity exists to identify market segments in development, such as real-world evidential marketplaces and preventative care, where clear market expansion exists. However, addressing key industry drivers is important for vendor solutions, as these shape the sustainable future of innovative and emergent commerce. Vendor solutions would need to evaluate necessary data privacy structures and interoperability as keys for continuing growth. Experts believe industry growth will belong to those who build sustainable vendor value chains and can demonstrate real improvements in patient outcomes, as the future could center around patient-based ecosystems.
- Oracle
- IBM
- SAS
- Allscripts Healthcare Solutions.
- MedeAnalytics
- Health Catalyst
- Apixio Inc.
Predictive Disease Analytics Market Future Outlook: Clinical AI, Multimodal Data & Preventive Care
The predictive disease analytics market is anticipated to experience continuous growth due to the transition of the healthcare system towards a preventive and analytics-based approach. The implementation of artificial intelligence, machine learning, and cloud computing in analytics has contributed to better disease prediction and decision-making in clinical settings. Higher demand for personalized medicine, telemedicine, and population health management creates possibilities for further development of the healthcare predictive analytics market.
Recent Predictive Disease Analytics Partnerships, Platforms & AI Deployments, 2025-2026
- April 2026: Labcorp announced the introduction of a new AI-powered real-world data platform, developed with Amazon Web Services (AWS) and Datavant. The company stated that the platform is designed to enable researchers and biopharmaceutical companies to analyze Alzheimer's disease-related data faster. (source: labcorp.com)
- September 2025: Renvio announced a strategic partnership with Klinrisk. The company stated that the alliance will enable the next generation of AI-enabled tools for kidney care natively integrated within Renvio's Dialysis Manager EMR at the point of care. (source: prnewswire.com)
Predictive Disease Analytics Market Scope, Segmentation & Forecast Period
| Report Attributes | Details |
| Market size value in 2025 | USD 3.49 billion |
| Market size value in 2026 | USD 4.25 billion |
| Revenue forecast in 2034 | USD 21.04 billion |
| CAGR | 22.20% from 2026 to 2034 |
| Base year | 2025 |
| Historical data | 2021–2024 |
| Forecast period | 2026–2034 |
| Quantitative units | Revenue in USD billion and CAGR from 2026 to 2034 |
| Segments covered | By Component, By Deployment, By End User, By Region |
| Regional scope | North America, Europe, Asia Pacific, Latin America, the Middle East & Africa |
| Key companies | Oracle, IBM, SAS, Allscripts Healthcare Solutions Inc., MedeAnalytics, Inc., Health Catalyst, and Apixio Inc. |
Source: Polaris Market Research Analysis
Predictive Disease Analytics Market FAQ's
The predictive disease analytics market report covering key segments are component, deployment, end-user, and region.
Predictive Disease Analytics Market Size Worth USD 21.04 Billion By 2034.
The global predictive disease analytics market expected to grow at a CAGR of 22.20% during the forecast period.
North America Led with 40.8% Share in 2025
key driving factors in predictive disease analytics market are rising cases of chronic diseases.
Predictive disease analytics involves the application of artificial intelligence, machine learning, and health care information to identify individuals who are at risk of contracting some diseases. Predictive disease analytics is useful in enabling health practitioners to diagnose diseases early, plan treatments, and attain good results.
The technologies utilized in the process of predicting diseases include artificial intelligence (AI), machine learning, big data analytics, cloud computing, and EHRs (electronic health records).
Use of predictive disease analytics facilitates the diagnosis of diseases early and better decision making in relation to clinical practices. Predictive disease analytics also assists in improving the quality of healthcare delivery and reducing admissions and healthcare costs.
Download Sample Report of Predictive Disease Analytics Market
Please fill out the form to request a customized copy of the research report.
